Ensuring we have a deep understanding of the person and their needs, what they value in a medicine or an intervention, and how this will impact their quality of life ... within a span of 12 ...

(Bassett, 1/29) MedPage Today: FDA Expands Enhertu Approval To HER2-Ultralow Breast Cancer ... (Monaco, 1/29) Axios: Racial Gaps In Life Expectancy Shrank Before COVID The gap in average life ...

ADHD’s rising prevalence has been met with some dismissiveness. As I wrote in 2023, questions have been raised about the ...

THE sudden and heartbreaking passing of legendary culinary entrepreneur Margarita Arañeta Forés at 65 years old again made us think of our own mortality, or what we refer to as our "life expectancy." ...

Life expectancy for Native Americans in the western U.S. dropped below 64 years. This is a KFF Health News story. The life expectancy among Native Americans in the western United States has ...

AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate (ADC) Enhertu (trastuzumab deruxtecan) has received approval from the US Food and Drug Administration (FDA) for an expanded indication of ...

Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.

Enhertu achieved a median progression-free survival of 13.2 months versus 8.1 months for chemotherapy, with a higher objective response rate of 62.6% compared to 34.4%. This summary was ...

AstraZeneca AZN and partner Daiichi Sankyo announced that the FDA has approved the supplemental biologics license application (sBLA) seeking approval for expanded use of Enhertu (trastuzumab ...

The survey also found that 64% of men believe the average life span will increase in their lifetime, compared to 50% of women. That gap is even more pronounced within younger generations ...